Percutaneous Coronary Intervention Registry FRIBOURG

NCT ID: NCT04185285

Last Updated: 2021-10-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

3000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-01

Study Completion Date

2027-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The registry aims to follow clinically all consecutive patients treated by percutaneous coronary interventions at hospital \& university Fribourg.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease Percutaneous Coronary Intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Percutaneous coronary intervention, stents

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All consecutive patients treated by percutaneous coronary intervention at our institution
* Able to give informed consent and willing to participate

Exclusion Criteria

* Unwillingness to participate
* Enable to provide inform consent
Minimum Eligible Age

17 Years

Maximum Eligible Age

120 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Freiburg

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stéphane Cook, Prof

Chairman, cardiology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Cardiology, university Fribourg Medical Center

Fribourg, , Switzerland

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Cook Y. Stephane, MD

Role: primary

+41263063800

Masset Lea, BSc

Role: backup

+41263063800

References

Explore related publications, articles, or registry entries linked to this study.

Cook ST, Allemann L, Cook M, Arroyo DA, Pittet T, Meier P, Togni M, Brahim-Mathiron A, Puricel S, Cook S. Sex differences in ST-segment elevation myocardial infarction patients treated by primary percutaneous intervention. Open Heart. 2025 Jan 4;12(1):e002831. doi: 10.1136/openhrt-2024-002831.

Reference Type DERIVED
PMID: 39756819 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

003-REP-CER-FR-2

Identifier Type: -

Identifier Source: org_study_id